PRAX
insider transactionsPraxis Precision Medicines, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
13.4K sh
Own New
-
Grant·A
Director
$0
6.0K sh
Own +7%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +72%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +8%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +118%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +142%
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own New
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own New
-
Grant·A
Director
$0
648 sh
Own New
-
Grant·A
Director
$0
1.4K sh
Own +118%
-
Grant·A
Chief Operating Officer
$14.9K
89 sh · $167.94
Own +0%
-
Grant·A
Marcio Souza KEY
Chief Executive Officer
$21.2K
126 sh · $167.94
Own +0%
-
Grant·A
General Counsel and Secretary
$13.1K
78 sh · $167.94
Own +0%
-
Grant·A
Principal Accounting Officer
$21.3K
127 sh · $167.94
Own +1%
-
Grant·A
Chief Financial Officer
$20.3K
121 sh · $167.94
Own +0%
-
Other·D
Director
—
1.7K sh
Own -100%
-
Other·D
Director
—
22.0K sh
Own -100%
-
Other·D
Director
—
28.5K sh
Own -100%
-
Other·D
Director
—
4.7K sh
Own -100%
-
Other·D
Director
—
10.7K sh
Own -100%
-
Other·D
Director
—
45.0K sh
Own -100%
-
Other·D
Director
—
32.0K sh
Own -100%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Dean J Mitchell | Grant A | 13.4K | $0 |
| Jun 12, 2026 | Dean J Mitchell | Grant A | 6.0K | $0 |
| Jun 10, 2026 | William D Young | Grant A | 648 | $0 |
| Jun 10, 2026 | William D Young | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Dean J Mitchell | Grant A | 648 | $0 |
| Jun 10, 2026 | Dean J Mitchell | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jeffrey B Kindler | Grant A | 648 | $0 |
| Jun 10, 2026 | Jeffrey B Kindler | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jill Desimone | Grant A | 648 | $0 |
| Jun 10, 2026 | Jill Desimone | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Merit Ester Cudkowicz | Grant A | 648 | $0 |
| Jun 10, 2026 | Merit Ester Cudkowicz | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Jeffrey Chodakewitz | Grant A | 648 | $0 |
| Jun 10, 2026 | Jeffrey Chodakewitz | Grant A | 1.4K | $0 |
| Jun 10, 2026 | Stuart A Arbuckle | Grant A | 648 | $0 |
| Jun 10, 2026 | Stuart A Arbuckle | Grant A | 1.4K | $0 |
| May 14, 2026 | Megan Sniecinski | Grant A | 89 | $14.9K |
| May 14, 2026 | Marcio Souza KEY | Grant A | 126 | $21.2K |
| May 14, 2026 | Alex Nemiroff | Grant A | 78 | $13.1K |
| May 14, 2026 | Lauren Mastrocola | Grant A | 127 | $21.3K |
| May 14, 2026 | Timothy Edwin Kelly KEY | Grant A | 121 | $20.3K |
| May 5, 2026 | Jeffrey B Kindler | Other D | 1.7K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 22.0K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 28.5K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 4.7K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 10.7K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 45.0K | — |
| May 5, 2026 | Jeffrey B Kindler | Other D | 32.0K | — |
About PRAX insider trading
This page tracks insider transactions for Praxis Precision Medicines, Inc. (PRAX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.